| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 8.90e-05 | 11 | 26 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.70e-04 | 151 | 26 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 9.99e-04 | 36 | 26 | 2 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 9.99e-04 | 36 | 26 | 2 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.04e-03 | 614 | 26 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.39e-03 | 441 | 26 | 4 | GO:0016887 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.50e-03 | 749 | 26 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.89e-03 | 465 | 26 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.94e-03 | 62 | 26 | 2 | GO:0019829 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.32e-03 | 66 | 26 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.32e-03 | 66 | 26 | 2 | GO:0001098 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.22e-04 | 78 | 26 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | presynaptic active zone | 6.97e-04 | 141 | 26 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | basal plasma membrane | 9.00e-04 | 354 | 26 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.15e-03 | 378 | 26 | 4 | GO:0045178 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.30e-03 | 43 | 26 | 2 | GO:0098688 | |
| MousePheno | abnormal grooming behavior | 3.05e-05 | 137 | 19 | 4 | MP:0001440 | |
| MousePheno | abnormal oxygen consumption | 1.21e-04 | 195 | 19 | 4 | MP:0005288 | |
| MousePheno | increased grooming behavior | 1.30e-04 | 74 | 19 | 3 | MP:0001441 | |
| MousePheno | stereotypic behavior | 1.73e-04 | 214 | 19 | 4 | MP:0001408 | |
| Domain | ATP_Ca_trans_C | 1.12e-05 | 4 | 26 | 2 | IPR022141 | |
| Domain | P-type_ATPase_IIB | 1.12e-05 | 4 | 26 | 2 | IPR006408 | |
| Domain | ATP_Ca_trans_C | 1.12e-05 | 4 | 26 | 2 | PF12424 | |
| Domain | - | 2.21e-04 | 16 | 26 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.21e-04 | 16 | 26 | 2 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.50e-04 | 17 | 26 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.50e-04 | 17 | 26 | 2 | PF00689 | |
| Domain | Cation_ATPase_N | 2.81e-04 | 18 | 26 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.81e-04 | 18 | 26 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.14e-04 | 19 | 26 | 2 | IPR004014 | |
| Domain | ATPase_P-typ_cyto_domN | 1.08e-03 | 35 | 26 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.14e-03 | 36 | 26 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 1.14e-03 | 36 | 26 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.14e-03 | 36 | 26 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.20e-03 | 37 | 26 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.20e-03 | 37 | 26 | 2 | PF00122 | |
| Domain | HAD-like_dom | 5.38e-03 | 79 | 26 | 2 | IPR023214 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.13e-04 | 12 | 19 | 2 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.55e-04 | 14 | 19 | 2 | MM15052 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.96e-04 | 681 | 19 | 6 | MM14985 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.60e-04 | 18 | 19 | 2 | M26942 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.00e-04 | 736 | 19 | 6 | M27287 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.02e-04 | 118 | 19 | 3 | M27316 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.92e-04 | 27 | 19 | 2 | MM15053 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 5.92e-04 | 27 | 19 | 2 | M26943 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.37e-04 | 28 | 19 | 2 | M924 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1313367 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 22252018 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25690014 | ||
| Pubmed | Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. | 5.37e-07 | 2 | 26 | 2 | 16216224 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 17689535 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20211863 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 3.22e-06 | 4 | 26 | 2 | 8634322 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 3.22e-06 | 4 | 26 | 2 | 12209837 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.22e-06 | 4 | 26 | 2 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 3.22e-06 | 4 | 26 | 2 | 11152753 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12784250 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 15101689 | ||
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 3.22e-06 | 4 | 26 | 2 | 36130203 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 23413890 | ||
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 3.22e-06 | 4 | 26 | 2 | 10434059 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.22e-06 | 4 | 26 | 2 | 8245032 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 10577388 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 17938178 | ||
| Pubmed | A SPAK isoform switch modulates renal salt transport and blood pressure. | 5.37e-06 | 5 | 26 | 2 | 21907141 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 12763866 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 11274188 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 8.05e-06 | 6 | 26 | 2 | 12767889 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 10951186 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 12189208 | ||
| Pubmed | 6.50e-05 | 1431 | 26 | 7 | 37142655 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.46e-04 | 695 | 26 | 5 | 23602568 | |
| Pubmed | 2.15e-04 | 29 | 26 | 2 | 15071553 | ||
| Pubmed | 2.17e-04 | 403 | 26 | 4 | 30562941 | ||
| Pubmed | SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair. | 2.97e-04 | 34 | 26 | 2 | 31495888 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.72e-04 | 38 | 26 | 2 | 30786075 | |
| Pubmed | 6.22e-04 | 225 | 26 | 3 | 12168954 | ||
| GeneFamily | ATPases Ca2+ transporting | 4.17e-05 | 9 | 20 | 2 | 1209 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.07e-05 | 145 | 26 | 3 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 26 | 3 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 26 | 3 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 1cff815536f620e32b9805666e1aa711462c2d25 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 31ea04e65876c42b90245d280f0b6439bfffbace | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 174 | 26 | 3 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 174 | 26 | 3 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 174 | 26 | 3 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 179 | 26 | 3 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-04 | 180 | 26 | 3 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 181 | 26 | 3 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 182 | 26 | 3 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 182 | 26 | 3 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-04 | 183 | 26 | 3 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 184 | 26 | 3 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 184 | 26 | 3 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 188 | 26 | 3 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 190 | 26 | 3 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 190 | 26 | 3 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 190 | 26 | 3 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 191 | 26 | 3 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 191 | 26 | 3 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | d2161842a38146261847fc9061ba9322e0f087e0 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 195 | 26 | 3 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 196 | 26 | 3 | 8faac7fbdee3a9297023c3151ef1751605413e44 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 196 | 26 | 3 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 196 | 26 | 3 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | 6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a | |
| Drug | strontium | 1.04e-06 | 68 | 26 | 4 | CID000104798 | |
| Drug | tBuBHQ | 1.10e-06 | 69 | 26 | 4 | CID000002374 | |
| Drug | 2brh | 1.73e-06 | 21 | 26 | 3 | CID000848641 | |
| Drug | AC1L25Y6 | 2.31e-06 | 23 | 26 | 3 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 2.31e-06 | 23 | 26 | 3 | CID000165791 | |
| Drug | cyhexatin | 2.99e-06 | 25 | 26 | 3 | CID005364545 | |
| Drug | magnesium | 9.44e-06 | 1325 | 26 | 9 | CID000000888 | |
| Drug | lanthanum | 1.64e-05 | 136 | 26 | 4 | CID000023926 | |
| Drug | LaCl3 | 2.07e-05 | 47 | 26 | 3 | CID000064735 | |
| Drug | nsc25485 | 2.43e-05 | 312 | 26 | 5 | CID000004605 | |
| Drug | CaCl2 | 2.82e-05 | 156 | 26 | 4 | CID000024854 | |
| Drug | AC1NSKPI | 3.71e-05 | 57 | 26 | 3 | CID005311482 | |
| Drug | toxaphene | 3.91e-05 | 58 | 26 | 3 | CID005284469 | |
| Drug | TMB-8 | 4.52e-05 | 176 | 26 | 4 | CID000005494 | |
| Drug | EGTA-AM | 4.78e-05 | 62 | 26 | 3 | CID000121907 | |
| Drug | 1sqc | 5.61e-05 | 10 | 26 | 2 | CID000444279 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.84e-05 | 188 | 26 | 4 | 6143_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HG-U133A | 6.34e-05 | 192 | 26 | 4 | 611_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 6.34e-05 | 192 | 26 | 4 | 4180_UP | |
| Drug | p-nitrophenyl phosphate | 6.60e-05 | 194 | 26 | 4 | CID000000378 | |
| Drug | 2,5-dimethylquinone | 6.85e-05 | 11 | 26 | 2 | CID000008718 | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; HL60; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 3064_UP | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 3564_UP | |
| Drug | caged ATP | 6.88e-05 | 70 | 26 | 3 | CID000123806 | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 6237_UP | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 2293_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4323_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 6088_UP | |
| Drug | Pyrethroids | 7.18e-05 | 71 | 26 | 3 | CID000005053 | |
| Drug | C070379 | 7.28e-05 | 199 | 26 | 4 | CID003034747 | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 6459_UP | |
| Drug | cocaethylene | 7.80e-05 | 73 | 26 | 3 | CID000002825 | |
| Drug | 1vyq | 8.22e-05 | 12 | 26 | 2 | CID004369390 | |
| Drug | Ro 46861 | 8.22e-05 | 12 | 26 | 2 | CID000003128 | |
| Drug | 8-hydroxycoumarin | 9.71e-05 | 13 | 26 | 2 | CID000122783 | |
| Drug | p-hydroxyhippuric acid | 1.13e-04 | 14 | 26 | 2 | CID000151012 | |
| Drug | AC1MMLID | 1.55e-04 | 92 | 26 | 3 | CID000013245 | |
| Drug | AC1L88YH | 1.69e-04 | 17 | 26 | 2 | CID000374551 | |
| Drug | chlorpromazine sulfoxide | 1.90e-04 | 18 | 26 | 2 | CID000070413 | |
| Drug | indo-1 | 1.93e-04 | 99 | 26 | 3 | CID000105060 | |
| Drug | fluo-3 | 3.57e-04 | 122 | 26 | 3 | CID000104978 | |
| Drug | dodecyl ether | 4.01e-04 | 26 | 26 | 2 | CID000020667 | |
| Drug | Benzyl [12-(2-Amino-2-Oxoethyl)-4-Nitro-10,13-Dioxo-15-[(Propylamino)carbonyl]-2-Oxa-11,14-Diazatricyclo[15 .2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-Hexaen-9-Yl]carbamate | 4.01e-04 | 26 | 26 | 2 | CID010062700 | |
| Drug | K-Cl | 4.01e-04 | 567 | 26 | 5 | CID000004873 | |
| Drug | triflupromazine | 4.32e-04 | 27 | 26 | 2 | CID000005568 | |
| Drug | BAPTA | 4.70e-04 | 324 | 26 | 4 | CID000104751 | |
| Drug | octaethylene glycol | 5.00e-04 | 29 | 26 | 2 | CID000078798 | |
| Drug | TBHQ | 5.45e-04 | 141 | 26 | 3 | CID000016043 | |
| Drug | sodium | 5.64e-04 | 944 | 26 | 6 | CID000000923 | |
| Drug | clotrimazole | 5.67e-04 | 143 | 26 | 3 | CID000002812 | |
| Drug | acepromazine | 5.71e-04 | 31 | 26 | 2 | CID000006077 | |
| Drug | nimodipine | 5.91e-04 | 145 | 26 | 3 | CID000004497 | |
| Drug | E1-P | 6.48e-04 | 33 | 26 | 2 | CID000104406 | |
| Drug | milrinone | 6.52e-04 | 150 | 26 | 3 | CID000004197 | |
| Drug | Bay K 8644 | 6.52e-04 | 150 | 26 | 3 | CID000002303 | |
| Drug | compound 48/80 | 6.65e-04 | 151 | 26 | 3 | CID000104735 | |
| Drug | fluorescamine | 7.29e-04 | 35 | 26 | 2 | CID000037927 | |
| Drug | oxalate | 7.58e-04 | 158 | 26 | 3 | CID000000971 | |
| Drug | calmidazolium chloride | 7.86e-04 | 160 | 26 | 3 | CID000002531 | |
| Drug | potassium | 7.97e-04 | 1008 | 26 | 6 | CID000000813 | |
| Drug | gramicidin s | 8.15e-04 | 37 | 26 | 2 | CID000073357 | |
| Drug | mag-fura-2 | 8.15e-04 | 37 | 26 | 2 | CID000123839 | |
| Drug | lignoceroyl-CoA | 9.05e-04 | 39 | 26 | 2 | CID003082227 | |
| Drug | 3-dinitrobenzene | 9.23e-04 | 388 | 26 | 4 | ctd:C017906 | |
| Drug | carbidine | 9.52e-04 | 40 | 26 | 2 | CID000065684 | |
| Drug | AC1L1IIA | 9.69e-04 | 172 | 26 | 3 | CID000004591 | |
| Drug | N-methylmesoporphyrin | 1.05e-03 | 42 | 26 | 2 | CID000444708 | |
| Drug | C12E8 | 1.05e-03 | 42 | 26 | 2 | CID000123921 | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 6045_UP | |
| Drug | linopirdine | 1.10e-03 | 43 | 26 | 2 | CID000003932 | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.12e-03 | 181 | 26 | 3 | 3275_DN | |
| Drug | octanoate | 1.12e-03 | 181 | 26 | 3 | CID000000379 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.03e-05 | 6 | 25 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 1.72e-04 | 23 | 25 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.72e-04 | 23 | 25 | 2 | C4521256 | |
| Disease | sporadic amyotrophic lateral sclerosis | 2.23e-04 | 140 | 25 | 3 | EFO_0001357 | |
| Disease | bipolar I disorder | 2.27e-04 | 141 | 25 | 3 | EFO_0009963 | |
| Disease | progressive supranuclear palsy | 3.16e-04 | 31 | 25 | 2 | MONDO_0019037 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 3.37e-04 | 32 | 25 | 2 | EFO_0021870 | |
| Disease | clopidogrel metabolite measurement | 3.58e-04 | 33 | 25 | 2 | EFO_0007966 | |
| Disease | carbohydrate measurement | 6.97e-04 | 46 | 25 | 2 | EFO_0004998 | |
| Disease | phenylalanine measurement | 9.96e-04 | 55 | 25 | 2 | EFO_0005001 | |
| Disease | sclerosing cholangitis | 1.43e-03 | 66 | 25 | 2 | EFO_0004268 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.84e-03 | 75 | 25 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.86e-03 | 291 | 25 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.36e-03 | 85 | 25 | 2 | EFO_0004639, EFO_0004732 | |
| Disease | lipid measurement, lipoprotein measurement | 2.64e-03 | 90 | 25 | 2 | EFO_0004529, EFO_0004732 | |
| Disease | economic and social preference | 3.05e-03 | 97 | 25 | 2 | EFO_0004827 | |
| Disease | RS-10-hydroxywarfarin measurement | 3.12e-03 | 98 | 25 | 2 | EFO_0803330 | |
| Disease | interleukin-6 measurement | 4.05e-03 | 112 | 25 | 2 | EFO_0004810 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 4.48e-03 | 118 | 25 | 2 | EFO_0010119 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.70e-03 | 121 | 25 | 2 | EFO_0004612, EFO_0005271 | |
| Disease | docosahexaenoic acid measurement | 5.17e-03 | 127 | 25 | 2 | EFO_0007761 | |
| Disease | polyunsaturated fatty acid measurement | 5.49e-03 | 131 | 25 | 2 | EFO_0010733 | |
| Disease | phospholipid measurement | 6.24e-03 | 140 | 25 | 2 | EFO_0004639 | |
| Disease | Bladder Neoplasm | 6.24e-03 | 140 | 25 | 2 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.33e-03 | 141 | 25 | 2 | C0005684 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.32e-03 | 152 | 25 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.41e-03 | 153 | 25 | 2 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.41e-03 | 153 | 25 | 2 | EFO_0004611, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EIDGVDVCFFGMHVQ | 1401 | Q92793 | |
| ADVGFAMGIAGTDVA | 831 | Q01814 | |
| ADVGFAMGIAGTDVA | 796 | P23634 | |
| MADILVVFARGAHGD | 156 | P39900 | |
| RFIAHGDADVMVAGG | 221 | Q9NWU1 | |
| HMEADGHAAVVFGTV | 186 | Q96RG2 | |
| HVGVMDSVAAAAAAA | 316 | Q5VYV0 | |
| VALAGAGAAVIAMVH | 216 | P51674 | |
| AALQADGHMIAFLGD | 401 | Q9ULL4 | |
| AGVAVHGGELAAAMT | 406 | P15863 | |
| GRGAFEAMAHVVSLV | 801 | Q96HP0 | |
| DCVVLMAAAGHFAGA | 206 | Q9H8Y5 | |
| LFEAMDFEGHGVEVS | 1266 | Q8N1P7 | |
| DGNGFVSAAELRHVM | 96 | P27482 | |
| EDGSMIIAHAFHGAL | 351 | Q6IA86 | |
| DEDGTLGFRAAHIMV | 1511 | Q9BYK8 | |
| AEVFAMVRAHVAALG | 921 | Q86YS7 | |
| GMGNEIDVHTAFFHG | 296 | Q9BQS7 | |
| NFFAGGEDCVVMVAH | 1176 | O14594 | |
| EQLFGAAGVMAIEHA | 301 | P78371 | |
| AAGVMAIEHADFAGV | 306 | P78371 | |
| FGGEMVAAVAEVSGH | 181 | Q6PCB7 | |
| ANAVGVAMHTVGFAE | 226 | P55017 | |
| DRHVGMAVAGLLADA | 71 | P25788 | |
| FVAGMAGTAHIDGDH | 26 | Q9Y462 | |
| MRYGADVDAGSIVHA | 441 | Q5R3F8 | |
| GDHVAGMLAVAVASS | 186 | Q5JTD7 |